Clinical trials - Press Releases

Date	Title	Company
12-Feb-2021	Innovation Sprint boosts the AI portfolio of Healthentia for clinical research and eHealth with new R&D projects	Innovation Sprint
12-Feb-2021	Global Medical Simulation Market is Anticipated to Reach $3,251 million by 2025 at a CAGR of 14.0% \| Apex Market Research	Apex Market Research
11-Feb-2021	Artios Pharma Announces the Start of First Clinical Study with the Dosing of its ATR Inhibitor, ART0380, to Patients	Artios Pharma
11-Feb-2021	Global Cancer Therapeutics Market In Depth Research with Industry Trends, Key Players and Forecast by 2026	Apex Market Research
10-Feb-2021	Two Exclusive Interviews Release with Pfizer and Novo Nordisk ahead of Pharmaceutical Microbiology East Coast Virtual Conference	SMi Group
09-Feb-2021	Medigene AG: Further encouraging results from long-term follow-up of AML patients in DC vaccine trial	Medigene AG
09-Feb-2021	Medidata Launches Sensor Cloud, Ushering in Next Generation Solution for Connected Devices and Wearable Sensors in Clinical Trials	Medidata
09-Feb-2021	4D pharma announces clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer to evaluate MRx0518 in combination with BAVENCIO(R) for the treatment of locally advanced or metastatic urothelial carcinoma	4D pharma
09-Feb-2021	Cardior's pioneering miRNA approach in heart failure endorsed by expert opinions in the European Heart Journal	Cardior Pharmaceuticals
09-Feb-2021	Global Brain Monitoring Market is Booming to Reach $6,595 Million Value Mark by 2025 \| Apex Market Research	Apex Market Research
08-Feb-2021	SPRAVATO® ▼ (Esketamine Nasal Spray) Authorised in Europe for the Rapid Reduction of Depressive Symptoms in a Psychiatric Emergency for Adult Patients with a Moderate to Severe Episode of Major Depressive Disorder	Janssen Cilag ltd
08-Feb-2021	PharmiWeb.Jobs Welcomes Biophorum	PharmiWeb.Jobs
05-Feb-2021	The Lancet Publishes Two Phase 3 Studies Detailing Bimekizumab Data in Moderate to Severe Plaque Psoriasis	UCB
05-Feb-2021	Achilles Therapeutics Announces Independent Data and Safety Monitoring Committee Review with a Positive Recommendation to Continue with Current Study Design of the Phase I/IIa CHIRON and THETIS Trials	Achilles Therapeutics
03-Feb-2021	Imcyse Enters into Research Collaboration and License Agreement for its ImotopeTM Technology with Pfizer in Rheumatoid Arthritis	Imcyse
03-Feb-2021	Imcyse Announces Start of Phase 1b/2a IMPACT Study in Patients with Recent Onset Type 1 Diabetes	Imcyse
03-Feb-2021	Three Key Start-ups Join SMi’s 2nd Annual AI in Drug Discovery Virtual Conference	SMi Group
02-Feb-2021	NEW HOPE FOR WOMEN WITH SUSPECTED ENDOMETRIAL CANCER AS INNOVATIVE URINE TEST RULES OUT DISEASE IN UP TO 99% OF CASES	Arquer Diagnostics
02-Feb-2021	Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD	Verona Pharma
02-Feb-2021	Bristol Myers Squibb Announces Positive Topline Results from Second Pivotal Phase 3 Psoriasis Study Showing Superiority of Deucravacitinib Compared to Placebo and Otezla® (apremilast)	Bristol Myers Squibb